JCR Pharmaceuticals' Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders | Region
HYOGO, Japan--(BUSINESS WIRE)--Feb 14, 2024--
Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HYOGO, Japan--(BUSINESS WIRE)--Feb 14, 2024--
NurExone Biologic launches licensing efforts for its ExoTherapy platform for creating nanodrugs by loading therapeutic molecular cargo into exosomes. ...
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build
JCR Pharmaceuticals Co., Ltd. announced today that it will present six presentations at the 20th Annual WORLDSymposiumâ„¢ 2024, to be held February 4-9, 2024 in San Diego, Calif. These presentations...
Ericsson and Telus Collaborate to Revolutionize Canada's 5G Network - OPP.Today